Literature DB >> 28371171

One-year treatment outcomes of ziv-aflibercept for treatment-naïve macular oedema in branch retinal vein occlusion.

Errol W Chan1,2, Mohab Eldeeb1, Chintan J Dedhia3, Ahmad Mansour4,5, Jay Chhablani3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28371171     DOI: 10.1111/aos.13432

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


× No keyword cloud information.
  1 in total

1.  Bevacizumab versus ziv-aflibercept in branch retinal vein occlusion.

Authors:  Imoro Z Braimah; Sumit Randhir Singh; Bhushan Uplanchiwar; Ahmad M Mansour; Jay Chhablani
Journal:  Indian J Ophthalmol       Date:  2019-07       Impact factor: 1.848

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.